Pharma & Biotech
Byrna Technologies’ self-defense weapon hits the bullseye with strong sales
Mandalay Resources well positioned with improvements in Australian and Swedish mines and disposal of non-operating assets
ImmunoPrecise Antibodies expecting significant revenue growth in 2019
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.